<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35398025</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-7786</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>360</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemico-biological interactions</Title>
          <ISOAbbreviation>Chem Biol Interact</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comprehensive insight into the neurotoxic mechanisms of low dose Pb exposure in Wistar rats: Benchmark dose analysis.</ArticleTitle>
        <Pagination>
          <StartPage>109932</StartPage>
          <MedlinePgn>109932</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cbi.2022.109932</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0009-2797(22)00137-5</ELocationID>
        <Abstract>
          <AbstractText>Lead (Pb) is a toxic metal that affects almost all human's system and organs, with the nervous system as the most sensitive. Better understanding of the Pb neurobehavioral effects and neurotoxicity requires realistic study scenarios based on low level exposure. The aim of this study was to determine neurotoxic effects and mechanisms of Pb in six low doses and to establish dose-response relationship for these effects and related Benchmark dose (BMD). Forty-two, male albino Wistar rats were randomized into seven groups, control and Pb-exposed: 0.1, 0.5, 1, 3, 7 and 15 mg Pb/kg body weight/day (oral gavage) for 28 days. Behavioural tests (Elevated plus maze test, Spontaneous locomotor activity test and Novel object recognition test) were conducted in the last week of experiment, in the control, lower (0.5 mg Pb/kg), middle (3 mg Pb/kg) and higher (15 mg Pb/kg) dose groups. The acetylcholinesterase activity, oxidative status and essential elements levels (Cu, Zn, Mn and Fe) were measured in brain tissue along with histological analyses. External and internal dose-response analyses were performed using PROASTweb 70.1 software. The results have shown that subacute exposure to very low doses of Pb resulted in memory deficits in rats that was accompanied with acetylcholinesterase enzyme activity decrease. The observed hyperactive behaviour was accompanied by dose-dependent induction of brain oxidative stress and Zn elevation. The histological alterations in Purkinje cells were only detected in the group treated with the highest Pb dose. The lowest BMD considering entire oxidative status was calculated based on total oxidative status (4.5e-06 mg Pb/kg b.w./day). The findings reported in our study may be beneficial in further evaluating the health consequences and human health risk assessment of low-level Pb exposure.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Javorac</LastName>
            <ForeName>Dragana</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia. Electronic address: dragana.javorac@pharmacy.bg.ac.rs.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anđelković</LastName>
            <ForeName>Milena</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Health Center Kosovska Mitrovica, 38220, Kosovska, Mitrovica, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Repić</LastName>
            <ForeName>Aleksandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Forensic Medicine, University of Belgrade - Faculty of Medicine, 11000, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tatović</LastName>
            <ForeName>Simona</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Djordjevic</LastName>
            <ForeName>Aleksandra Buha</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miljaković</LastName>
            <ForeName>Evica Antonijević</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Batinić</LastName>
            <ForeName>Bojan</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boričić</LastName>
            <ForeName>Novica</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Pathology, University of Belgrade - Faculty of Medicine, 11000, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Đukić-Ćosić</LastName>
            <ForeName>Danijela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antonijević</LastName>
            <ForeName>Biljana</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bulat</LastName>
            <ForeName>Zorica</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", University of Belgrade - Faculty of Pharmacy, 11221, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Ireland</Country>
        <MedlineTA>Chem Biol Interact</MedlineTA>
        <NlmUniqueID>0227276</NlmUniqueID>
        <ISSNLinking>0009-2797</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>2P299V784P</RegistryNumber>
          <NameOfSubstance UI="D007854">Lead</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.7</RegistryNumber>
          <NameOfSubstance UI="D000110">Acetylcholinesterase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000110" MajorTopicYN="Y">Acetylcholinesterase</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007854" MajorTopicYN="N">Lead</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020258" MajorTopicYN="Y">Neurotoxicity Syndromes</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dose-response analysis</Keyword>
        <Keyword MajorTopicYN="N">Essential elements</Keyword>
        <Keyword MajorTopicYN="N">Low lead levels</Keyword>
        <Keyword MajorTopicYN="N">Neurotoxicity</Keyword>
        <Keyword MajorTopicYN="N">Purkinje cells</Keyword>
        <Keyword MajorTopicYN="N">Redox status</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>10</Day>
          <Hour>20</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35398025</ArticleId>
        <ArticleId IdType="doi">10.1016/j.cbi.2022.109932</ArticleId>
        <ArticleId IdType="pii">S0009-2797(22)00137-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
